Endoscopic eradication of Barrett's esophagus

Gastrointestinal Endoscopy

Volumn 71, Issue 1, 2010, Pages 147-166

  Wani, Sachin ^a   Sayana, Hari ^a   Sharma, Prateek ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL FEATURE; CRYOTHERAPY; DISEASE COURSE; ENDOSCOPIC SURGERY; ESOPHAGUS RESECTION; HUMAN; MORBIDITY; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT RESPONSE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; PRECANCEROUS CONDITIONS;

EID: 73049099812     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.07.026     Document Type: Review

References (140)

1. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 127 (2004) 310-330
2. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
3. Haggitt R.C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25 (1994) 982-993
4. Williamson W.A., Ellis Jr. F.H., Gibb S.P., et al. Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg 49 (1990) 537-541 discussion 541-2
5. Peters F.T., Ganesh S., Kuipers E.J., et al. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut 45 (1999) 489-494
6. Lerut T., Coosemans W., Van Raemdonck D., et al. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg 107 (1994) 1059-1065 discussion 1065-6
7. Heitmiller R.F., Redmond M., and Hamilton S.R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
8. Konda V.J., Ross A.S., Ferguson M.K., et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?. Clin Gastroenterol Hepatol 6 (2008) 159-164
9. Oberg S., Johansson J., Wenner J., et al. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 235 (2002) 338-345
10. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
11. Guyatt G., Gutterman D., Baumann M.H., et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 129 (2006) 174-181
12. Atkins D., Best D., Briss P.A., et al. Grading quality of evidence and strength of recommendations. Br Med J 328 (2004) 1490
13. Falck-Ytter Y., Kunz R., Guyatt G.H., et al. How strong is the evidence?. Am J Gastroenterol 103 (2008) 1334-1338
14. American Society for Gastrointestinal Endoscopy Technical Committee. Mucosal ablation devices. Gastrointest Endosc 68 (2008) 1031-1042
15. Kantsevoy S.V., Adler D.G., Conway J.D., et al. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc 68 (2008) 11-18
16. Petersen B.T., Chuttani R., Croffie J., et al. Photodynamic therapy for gastrointestinal disease. Gastrointest Endosc 63 (2006) 927-932
17. Dumot J., and Greenwald B.D. Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC's of ablative techniques. Endoscopy 40 (2008) 1026-1032
18. Yeh R., and Triadafilopoulos G. Endoscopic therapy for Barrett's esophagus. Gastrointest Endosc Clin N Am 15 (2005) 377-397
19. Mork H., Barth T., Kreipe H.H., et al. Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study. Scand J Gastroenterol 33 (1998) 1130-1134
20. Van Laethem J.L., Cremer M., Peny M.O., et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 43 (1998) 747-751
21. Byrne J.P., Armstrong G.R., and Attwood S.E. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 93 (1998) 1810-1815
22. Grade A.J., Shah I.A., Medlin S.M., et al. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc 50 (1999) 18-22
23. Pereira-Lima J.C., Busnello J.V., Saul C., et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 95 (2000) 1661-1668
24. Schulz H., Miehlke S., Antos D., et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 51 (2000) 659-663
25. Morris C.D., Byrne J.P., Armstrong G.R., et al. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation. Br J Surg 88 (2001) 1357-1362
26. Tigges H., Fuchs K.H., Maroske J., et al. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J Gastrointest Surg 5 (2001) 251-259
27. Kahaleh M., Van Laethem J.L., Nagy N., et al. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34 (2002) 950-955
28. Basu K.K., Pick B., Bale R., et al. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 51 (2002) 776-780
29. Morino M., Rebecchi F., Giaccone C., et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication. Surg Endosc 17 (2003) 539-542
30. Pagani M., Granelli P., Chella B., et al. Barrett's esophagus: combined treatment using argon plasma coagulation and laparoscopic antireflux surgery. Dis Esophagus 16 (2003) 279-283
31. Familiari L., Scaffidi M., Bonica M., et al. Endoscopic treatment of Barrett's epithelium with argon plasma coagulation. Long-term follow-up. Minerva Gastroenterol Dietol 49 (2003) 63-70
32. Kelty C.J., Ackroyd R., Brown N.J., et al. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther 20 (2004) 1289-1296
33. Hage M., Siersema P.D., van Dekken H., et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 53 (2004) 785-790
34. Ackroyd R., Tam W., Schoeman M., et al. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. Gastrointest Endosc 59 (2004) 1-7
35. Pinotti A.C., Cecconello I., Filho F.M., et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation: a prospective study after fundoplication. Dis Esophagus 17 (2004) 243-246
36. Dulai G.S., Jensen D.M., Cortina G., et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 61 (2005) 232-240
37. Pedrazzani C., Catalano F., Festini M., et al. Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. World J Gastroenterol 11 (2005) 1872-1875
38. Madisch A., Miehlke S., Bayerdorffer E., et al. Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation. World J Gastroenterol 11 (2005) 1182-1186
39. Sharma P., Wani S., Weston A.P., et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 55 (2006) 1233-1239
40. Manner H., May A., Miehlke S., et al. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol 101 (2006) 1762-1769
41. Bright T., Watson D.I., Tam W., et al. Randomized trial of argon plasma coagulation versus endoscopic surveillance for Barrett esophagus after antireflux surgery: late results. Ann Surg 246 (2007) 1016-1020
42. Mork H., Al-Taie O., Berlin F., et al. High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation. Scand J Gastroenterol 42 (2007) 23-27
43. Ferraris R., Fracchia M., Foti M., et al. Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence. Aliment Pharmacol Ther 25 (2007) 835-840
44. Formentini A., Schwarz A., Straeter J., et al. Treatment of Barrett's esophagus with argon plasma coagulation and antireflux surgery. A retrospective analysis. Hepatogastroenterology 54 (2007) 1991-1996
45. Bright T., Watson D.I., Tam W., et al. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication. Dig Dis Sci (2008 Dec 20) [Epub ahead of print]
46. Ragunath K., Krasner N., Raman V.S., et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 40 (2005) 750-758
47. Van Laethem J.L., Jagodzinski R., Peny M.O., et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 33 (2001) 257-261
48. Attwood S.E., Lewis C.J., Caplin S., et al. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 1 (2003) 258-263
49. Sampliner R. Ablative therapies for the columnar-lined esophagus. Gastroenterol Clin North Am 26 (1997) 685-694
50. Sharma P., Bhattacharyya A., Garewal H.S., et al. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc 50 (1999) 159-164
51. Montes C.G., Brandalise N.A., Deliza R., et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 50 (1999) 173-177
52. Sampliner R.E., Faigel D., Fennerty M.B., et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53 (2001) 554-558
53. Barham C.P., Jones R.L., Biddlestone L.R., et al. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 41 (1997) 281-284
54. Salo J.A., Salminen J.T., Kiviluoto T.A., et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 227 (1998) 40-44
55. Gossner L., May A., Stolte M., et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 49 (1999) 8-12
56. Weston A.P., and Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 97 (2002) 2998-3006
57. Fisher R.S., Bromer M.Q., Thomas R.M., et al. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation. Am J Gastroenterol 98 (2003) 1945-1951
58. Bowers S.P., Mattar S.G., Waring P.J., et al. KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate. Surg Endosc 17 (2003) 49-54
59. Wang K., Lutzke L., Borkenhagen L., et al. Photodynamic therapy for Barrett's esophagus: does light still have a role?. Endoscopy 40 (2008) 1021-1025
60. Ortner M.A., Zumbusch K., Liebetruth J., et al. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. Endoscopy 34 (2002) 611-616
61. Overholt B.F., Panjehpour M., and Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49 (1999) 1-7
62. Ackroyd R., Kelty C.J., Brown N.J., et al. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. Endoscopy 35 (2003) 496-501
63. Overholt B.F., Panjehpour M., and Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 58 (2003) 183-188
64. Gossner L., Stolte M., Sroka R., et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 114 (1998) 448-455
65. Wolfsen H.C., Woodward T.A., and Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77 (2002) 1176-1181
66. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14 (2002) 1085-1091
67. Javaid B. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahidroxyphenyl chlorin): a preliminary study. Lasers Med Sci 17 (2002) 135
68. Wolfsen H.C., Hemminger L.L., Wallace M.B., et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther 20 (2004) 1125-1131
69. Etienne J., Dorme N., Bourg-Heckly G., et al. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 59 (2004) 880-889
70. Lovat L.B., Jamieson N.F., Novelli M.R., et al. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc 62 (2005) 617-623
71. Pech O., Gossner L., May A., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 (2005) 24-30
72. Weiss A.A., Wiesinger H.A., and Owen D. Photodynamic therapy in Barrett's esophagus: results of treatment of 17 patients. Can J Gastroenterol 20 (2006) 261-264
73. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
74. Overholt B.F., Wang K.K., Burdick J.S., et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 66 (2007) 460-468
75. Keeley S.B., Pennathur A., Gooding W., et al. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol 14 (2007) 2406-2410
76. Dunkin B.J., Martinez J., Bejarano P.A., et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 20 (2006) 125-130
77. Smith C.D., Bejarano P.A., Melvin W.S., et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 21 (2007) 560-569
78. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
79. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 68 (2008) 867-876
80. Ganz R.A., Overholt B.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 68 (2008) 35-40
81. Hernandez J.C., Reicher S., Chung D., et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 40 (2008) 388-392
82. Pouw R.E., Gondrie J.J., Sondermeijer C.M., et al. Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg 12 (2008) 1627-1636 discussion 1636-7
83. Roorda A.K., Marcus S.N., and Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus 20 (2007) 516-522
84. Shaheen N.J., Sharma P., Overholt B.F., et al. A randomized trial of radiofrequency ablation for Barrett's esophagus with dysplasia. N Engl J Med 360 (2009) 2277-2288
85. Sharma V.K., Kim H.J., Das A., et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 40 (2008) 380-387
86. Johnston M., Eastone J.A., Horwat J.D., et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc 62 (2005) 842-848
87. Greenwald B., Horwhat J.D., Abrams J.A., et al. Endoscopic cryoablation is safe and well-tolerated in Barrett's esophagus, esophageal dysplasia and esophageal cancer (abstract). Gastrointest Endosc 67 (2008) AB76
88. Johnston M., Cash B.E., Dykes C.A., et al. Cryoablation of dysplasia in Barrett's esophagus (BE) and early stage cancer [abstract]. Gastrointest Endosc 63 (2006) AB223
89. Dumot J., Vargo J.J., Zuccaro G., et al. Results of cryospray ablation for esophageal high grade dysplasia (HGD) and intramucosal cancer (IMC) in high risk non-surgical patients [abstract]. Gastrointest Endosc 67 (2008) AB176
90. Inoue H., Endo M., Takeshita K., et al. Endoscopic resection of early-stage esophageal cancer. Surg Endosc 5 (1991) 59-62
91. Giovannini M., Bories E., Pesenti C., et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36 (2004) 782-787
92. Seewald S., Akaraviputh T., Seitz U., et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57 (2003) 854-859
93. Peters F.P., Kara M.A., Rosmolen W.D., et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101 (2006) 1449-1457
94. Conio M., Repici A., Cestari R., et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol 11 (2005) 6650-6655
95. Soehendra N., Seewald S., Groth S., et al. Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video). Gastrointest Endosc 63 (2006) 847-852
96. Peters F.P., Kara M.A., Curvers W.L., et al. Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol 19 (2007) 311-315
97. Abrams J.A., Fedi P., Vakiani E., et al. Depth of resection using two different endoscopic mucosal resection techniques. Endoscopy 40 (2008) 395-399
98. Nijhawan P.K., and Wang K.K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 52 (2000) 328-332
99. Larghi A., Lightdale C.J., Ross A.S., et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 39 (2007) 1086-1091
100. Lopes C.V., Hela M., Pesenti C., et al. Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc 21 (2007) 820-824
101. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 57 (2008) 1200-1206
102. Sharma V.K., Kim J.H., Das A., et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 104 (2009) 310-317
103. Waxman I., Raju G.S., Critchlow J., et al. High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol 101 (2006) 1773-1779
104. May A., Gunter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 53 (2004) 634-640
105. Larghi A., Lightdale C.J., Memeo L., et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 62 (2005) 16-23
106. Sayana H., Wani S., Keighley J.D., et al. Endoscopic mucosal resection (EMR) as a diagnostic tool in Barrett's esophagus (BE) patients with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC): a systematic review. Gastroenterology 134 (2008) A-724
107. Hur C., Nishioka N.S., and Gazelle G.S. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 48 (2003) 1273-1283
108. Shaheen N.J., Inadomi J.M., Overholt B.F., et al. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut 53 (2004) 1736-1744
109. Comay D., Blackhouse G., Goeree R., et al. Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. Can J Gastroenterol 21 (2007) 217-222
110. Peters F.P., Kara M.A., Rosmolen W.D., et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 61 (2005) 506-514
111. Yachimski P., Puricelli W.P., and Nishioka N.S. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc 69 (2009) 205-212
112. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 132 (2007) 1226-1233
113. Das A., Singh V., Fleischer D.E., et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103 (2008) 1340-1345
114. Wei J., Sharma P., and Shaheen N.J. Endoscopic ablation therapies for Barrett's esophagus: a systematic review and meta-analysis of stricture complication. Am J Gastroenterol 98 (2003) S33
115. Prasad G.A., Wang K.K., Buttar N.S., et al. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 65 (2007) 60-66
116. Yachimski P., Puricelli W.P., and Nishioka N.S. Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol 6 (2008) 302-308
117. Odze R., and Lauwers G.Y. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy 40 (2008) 1008-1015
118. Hornick J., Blount P.L., Sanchez C.A., et al. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol 29 (2005) 372-380
119. Van Laethem J., Peny M.O., Salmon I., et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 46 (2000) 574-577
120. Mino-Kenudson M., Ban S., Obana M., et al. Buried dysplasia and early adenocarcinoma arising in Barrett's esophagus after porfimer-photodynamic therapy. Am J Pathol 31 (2007) 403-409
121. Bronner M.P., Overholt B.F., Taylor S.L., et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 136 (2009) 56-64
122. Hornick J., Mino-Kenudson M., Lauwers G., et al. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 103 (2008) 38-47
123. Krishnadath K.K., Wang K.K., Taniguchi K., et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 119 (2000) 624-630
124. Wani S., Puli S.R., Shaheen N.J., et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 104 (2009) 502-513
125. Odze R.D. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 59 (2006) 1029-1038
126. Rastogi A., Puli S., El-Serag H.B., et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 67 (2008) 394-398
127. Shaheen N.J., Crosby M.A., Bozymski E.M., et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 119 (2000) 333-338
128. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 4 (2006) 566-572
129. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 138 (2003) 176-186
130. Dvorak K., Ramsey L., Payne C.M., et al. Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg 244 (2006) 1031-1036
131. Sharma P., Falk G.W., Sampliner R.E., et al. Management of non dysplastic Barrett's esophagus: where are we now?. Am J Gastroenterol 104 (2009) 805-808
132. Wani S., Mathur S.M., and Sharma P. How to manage a Barrett's esophagus patient with low-grade dysplasia. Clin Gastroenterol Hepatol 7 (2009) 27-32
133. Wani S., Falk G., Sampliner R.E., et al. Low-grade dysplasia (LGD) is a poor marker for cancer progression in patients with Barrett's esophagus (BE): preliminary results from a large, multicenter, cohort study. Gastroenterology 136 (2009) A592
134. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation. Hum Pathol 32 (2001) 368-378
135. Stein H.J., Feith M., Mueller J., et al. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 232 (2000) 733-742
136. Manner H., May A., Pech O., et al. Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 103 (2008) 2589-2597
137. Sharma P., Dent J., Armstrong D., et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 131 (2006) 1392-1399
138. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 58 (2003) S3-43
139. Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 37 (2005) 570-578
140. Prasad G.A., Wang K.K., Halling K.C., et al. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. Gastroenterology 135 (2008) 370-379